Sean Yoder
Impact in
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Cytokine Signaling Pathways and Interactions
- Hematology top 5%
- Acute Myeloid Leukemia Research
Papers in
- Oncology 28
- Cancer Immunotherapy and Biomarkers 7
- CAR-T cell therapy research 6
- Pancreatic and Hepatic Oncology Research 5
-
- Cancer Genomics and Diagnostics 6
- Co-authors
- Jamie K. Teer (19 shared papers)Thomas P. Loughran (3 shared papers)Ravi Kothapalli (2 shared papers)Shrikant Mane (1 shared paper)Andrew Scott Brohl (6 shared papers)Damon R. Reed (6 shared papers)Steven Eschrich (7 shared papers)Elliot Kahen (2 shared papers)
- Journals
- Blood (9 papers)Scientific Reports (8 papers)PLoS ONE (3 papers)Oncotarget (3 papers)Journal for ImmunoTherapy of Cancer (3 papers)
- Partner nations
- United StatesPuerto RicoUnited Kingdom
In The Last Decade
Sean Yoder
84 papers receiving 2.9k citations
Sean Yoder's Hit Papers
Peers
Comparison fields: 5 of 105
- Oncology 1.1k
- Hematology 373
- Cancer Research 300
- Geriatrics and Gerontology 41
- Immunology 220
Countries citing papers authored by Sean Yoder
This map shows the geographic impact of Sean Yoder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sean Yoder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sean Yoder more than expected).
Fields of papers citing papers by Sean Yoder
This network shows the impact of papers produced by Sean Yoder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sean Yoder. The network helps show where Sean Yoder may publish in the future.
Co-authors
The 25 scholars most cited alongside Sean Yoder, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2006 | 490 | |
| 2 | Tumor-infiltrating lymphocyte treatment for anti-PD-1-resistant metastatic lung cancer: a phase 1 trial Hit paper breakdown → | 2021 | 343 |
| 3 | 2016 | 263 | |
| 4 | 2002 | 223 | |
| 5 | 2019 | 129 | |
| 6 | 2017 | 127 | |
| 7 | 2020 | 109 | |
| 8 | 2018 | 99 | |
| 9 | 2019 | 97 | |
| 10 | 2009 | 57 | |
| 11 | 2017 | 57 | |
| 12 | 2020 | 49 | |
| 13 | 2016 | 47 | |
| 14 | 2015 | 46 | |
| 15 | 2015 | 43 | |
| 16 | 2017 | 40 | |
| 17 | 2018 | 39 | |
| 18 | 2014 | 35 | |
| 19 | 2018 | 35 | |
| 20 | 2020 | 32 |
About Sean Yoder
Sean Yoder is a scholar working on Oncology, Cancer Research, Hematology, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 84 papers that have together received 2.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (8 papers), Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (6 papers), CAR-T cell therapy research (6 papers), Cancer Genomics and Diagnostics (6 papers), Ovarian cancer diagnosis and treatment (5 papers), Gene expression and cancer classification (5 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Oncology (1.1k citations), Hematology (373 citations), Cancer Research (300 citations), Geriatrics and Gerontology (41 citations) and Immunology (220 citations). Sean Yoder has collaborated with scholars based in United States, Puerto Rico and United Kingdom. Frequent co-authors include Jamie K. Teer, Thomas P. Loughran, Ravi Kothapalli, Shrikant Mane, Andrew Scott Brohl, Damon R. Reed, Steven Eschrich, Elliot Kahen, Steve Enkemann and Sangkil Nam. Their work appears in journals such as Blood, Scientific Reports, PLoS ONE, Oncotarget and Journal for ImmunoTherapy of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.